We assess your candidacy, source both peptides from 503A pharmacies, and monitor your progress across the full treatment cycle
CagriSema: GI adverse events reported by 79.6% (vs 39.9% placebo) in REDEFINE 1, mostly transient and mild to moderate
The vote took place during a two-day meeting discussing whether compounding pharmacies can fill prescriptions for some unapproved peptides
A growth hormone secretagogue administered to a sleep-deprived, under-recovered individual will not produce the same result as the same compound in someone with optimized sleep architecture and adequate protein intake
"Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance." Diabetologia
To explore all available peptide formats, along with in-depth information on their potential benefits and research findings, please visit our main BPC-157 Peptide page